| ★ |  Understanding IL-36 Signaling in GPP and Related Neutrophilic Dermatoses | | 6 | Estados Unidos | |
| 16 |  Psoriasis y enfermedad hepática: sinergia entre IMIDs | Centro MédicoTeknon @centromedicoteknon | — | — | 85 |
| 17 |  Dermatose nodulaire : "Plus aucun cas en France" depuis le 2 janvier 2026 | | — | Francia | 85 |
| 11 |  ROUGEUR sur la peau, psoriasis, eczéma... Notre dermatologue donne 4 CONSEILS pour bien l'utiliser. | | 71.6K | Francia | 85 |
| 18 |  PSORIASIS: ¿Por qué es clave el manejo conjunto entre dermatólogos y reumatólogos? | | 1.6K | Puerto Rico | 85 |
| 12 |  From basics to updates for cutaneous lupus erythematosus (CLE) | | 1.1K | — | 85 |
| 14 |  GP-SOD Plus Targeted Phototherapy Improves Vitiligo Repigmentation | | 249 | Estados Unidos | 85 |
| 10 |  What Is Next for OX40 Ligand Inhibition in Atopic Dermatitis? | | 91 | Estados Unidos | 85 |
| 15 |  Nuevas tecnologías de la información | Centro MédicoTeknon @centromedicoteknon | 72 | — | 85 |
| 13 |  GP-SOD Plus Targeted Phototherapy for Vitiligo: Safety, Dosing, Next Steps | | 60 | Estados Unidos | 85 |
| 7 |  A New Era of Generalized Pustular Psoriasis Care | | 14 | Estados Unidos | 88 |
| 19 |  What is the Role of Immunology in Atopic Dermatitis Care? With Jay Lieberman, MD | | 13 | Estados Unidos | 84 |
| 2 |  Improving Recognition and Diagnosis of GPP | | 7 | Estados Unidos | 89 |
| 4 |  Moving GPP Care Forward: From Awareness to Action | | 7 | Estados Unidos | 89 |
| 5 |  GPP vs. Plaque Psoriasis: Differentiation and Treatment Considerations | | 7 | Estados Unidos | 89 |
| 8 |  Why Early GPP Treatment is Critical | | 6 | Estados Unidos | 87 |
| 1 |  Recognizing and Managing Acute GPP Flares | | 3 | Estados Unidos | 90 |
| 9 |  Defining Treatment Success in GPP | | 3 | Estados Unidos | 87 |
| 3 |  Identifying GPP: Clinical Clues Across Phases | | 2 | Estados Unidos | 89 |
| 6 |  A Personalized Approach to GPP Care | | 2 | Estados Unidos | 88 |